Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome

Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):620-7. doi: 10.1016/j.numecd.2011.04.010. Epub 2011 Aug 19.

Abstract

Investigating cholesterol metabolism, which derives from balancing cholesterol synthesis and absorption, opens new perspectives in the pathogenesis of dyslipidemias and the metabolic syndrome (MS). Cholesterol metabolism is studied by measuring plasma levels of campesterol, sitosterol and cholestanol, that is, plant sterols which are recognised as surrogate cholesterol-absorption markers and lathosterol or squalene, that is, cholesterol precursors, which are considered surrogate cholesterol-synthesis markers. This article presents current knowledge on cholesterol synthesis and absorption, as evaluated by means of cholesterol precursors and plant sterols, and discusses patterns of cholesterol balance in the main forms of primary hyperlipidaemia and MS. Understanding the mechanism(s) underlying these patterns of cholesterol synthesis and absorption will help to predict the response to hypolipidemic treatment, which can then be tailored to ensure the maximum clinical benefit for patients.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood
  • Cholestanol / blood
  • Cholesterol / analogs & derivatives
  • Cholesterol / blood
  • Cholesterol / metabolism*
  • Dyslipidemias / physiopathology*
  • Dyslipidemias / therapy*
  • Humans
  • Lipid Metabolism
  • Metabolic Syndrome / physiopathology*
  • Metabolic Syndrome / therapy*
  • Phytosterols / blood
  • Sitosterols / blood

Substances

  • Biomarkers
  • Phytosterols
  • Sitosterols
  • campesterol
  • gamma-sitosterol
  • Cholestanol
  • Cholesterol